Sleep disturbances and excessive daytime sleepiness in Parkinson disease: An overview

Journal of Neural Transmission, Supplement

Volumn , Issue 70, 2006, Pages 349-355

  Comella, C L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; APOMORPHINE; CABERGOLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLOZAPINE; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; LEVODOPA; MELATONIN; MODAFINIL; OPIATE; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; SELEGILINE;

CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONFUSION; DAYTIME SOMNOLENCE; HALLUCINATION; HUMAN; NERVE DEGENERATION; NIGHT SLEEP; PARASOMNIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; RESTLESS LEGS SYNDROME; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDER;

EID: 33750333571     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-45295-0_53     Document Type: Conference Paper

References (82)

1. Adler CH, Caviness JN, et al. (2003) Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 18(3): 287-293
2. Albin RL, Koeppe RA, et al. (2000) Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 55(9): 1410-1412
3. Arnulf I, Bonnet AM, et al. (2000) Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 55(2): 281-288
4. Arnulf I, Konofal E, et al. (2002) Parkinson's disease and sleepiness: an integral part of PD. Neurology 58(7): 1019-1024
5. Askenasy JJ, Weitzman ED, et al. (1987) Are periodic movements in sleep a basal ganglia dysfunction? J Neural Transm 70(3-4): 337-347
6. Askenasy JJ, Yahr MD (1985) Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study. Neurology 35(4): 527-532
7. Baumann C, Ferini-Strambi L, et al. (2005) Parkinsonism with excessive daytime sleepiness - a narcolepsylike disorder?" J Neurol 252(2): 139-145
8. Boeve BF, Silber MH, et al. (2003) Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 4(4): 281-284
9. Boeve BF, Silber MH, et al. (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16(4): 622-630
10. Boeve BF, Silber MH, et al. (2003) Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 61(1): 40-45
11. Braga-Neto P, da Silva FP Jr, et al. (2004) Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 217(1): 41-45
12. Chiu HF, Wing YK, et al. (2000) Sleep-related injury in the elderly - an epidemiological study in Hong Kong. Sleep 23(4): 513-517
13. Comella CL (2003) Sleep disturbances in Parkinson's disease. Curr Neurol Neurosci Rep 3(2): 173-180
14. Comella CL, Morrissey M, et al. (2005) Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology 64(8): 1450-1451
15. Comella CL, Nardine TM, et al. (1998) Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 51(2): 526-529
16. Comella CL, Tanner CM, et al. (1993) Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 34(5): 710-714
17. Drouot X, Moutereau S, et al. (2003) Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 61(4): 540-543
18. Dyken ME, Lin-Dyken DC, et al. (1995) Violent sleep-related behavior leading to subdural hemorrhage. Arch Neurol 52(3): 318-321
19. Eisensehr I, Linke R, et al. (2003) Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 26(5): 507-512
20. Eisensehr I, Lindeiner Hv, et al. (2001) REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson's disease: is there a need for polysomnography? J Neurol Sci 186(1-2): 7-11
21. Factor SA, Feustel PJ, et al. (2003) Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 60(11): 1756-1761
22. Factor SA, McAlarney T, et al. (1990) Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 5(4): 280-285
23. Fantini ML, Gagnon JF, et al. (2003) The effects of pramipexole in REM sleep behavior disorder. Neurology 61(10): 1418-1420
24. Fenelon G, Mahieux F, et al. (2000) Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123(Pt 4): 733-745
25. Ferini-Strambi L (2002) Restless legs syndrome augmentation and pramipexole treatment. Sleep Med 3 [Suppl]: S23-S25
26. Ferini-Strambi L, Franceschi M, et al. (1992) Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 38(1-2): 92-98
27. Fernandez HH, Friedman JH, et al. (1999) Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 14(3): 484-487
28. Friedman JH, Fernandez HH (2002) Atypical antipsychotics in Parkinson-sensitive populations. J Geriatr Psychiatry Neurol 15(3): 156-170
29. Frucht S, Rogers JD, et al. (1999) Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52(9): 1908-1910
30. Frucht SJ, Greene PE, et al. (2000) Sleep episodes in Parkinson's disease: a wake-up call. Mov Disord 15(4): 601-603
31. Gagnon JF, Bedard MA, et al. (2002) REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 59(4): 585-589
32. Garcia-Borreguero D, Odin P, et al. (2003) Restless legs syndrome and PD: a review of the evidence for a possible association. Neurology 61[6 Suppl 3]: S49-S55
33. Gilman S, Koeppe RA, et al. (2003) REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology 61(1): 29-34
34. Gjerstad MD, Aarsland D, et al. (2002) Development of daytime somnolence over time in Parkinson's disease. Neurology 58(10): 1544-1546
35. Happe S, Pirker W, et al. (2003) Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding. J Neurol 250(1): 83-86
36. Happe S, Schrodl B, et al. (2001) Sleep disorders and depression in patients with Parkinson's disease. Acta Neurol Scand 104(5): 275-280
37. Happe S, Trenkwalder C (2003) Movement disorders in sleep: Parkinson's disease and restless legs syndrome. Biomed Tech (Berl) 48(3): 62-67
38. Hauser RA, Gauger L, et al. (2000) Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 15(4): 658-663
39. Hirsch EC, Graybiel AM, et al. (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 84(16): 5976-5980
40. Hobson DE, Lang AE, et al. (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. Jama 287(4): 455-463
41. Hogl B, Rothdach A, et al. (2003) The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease. Neuropsychopharmacology 28(10): 1866-1870
42. Hogl B, Saletu M, et al. (2002) Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 25(8): 905-909
43. Hogl B, Seppi K, et al. (2003) Increased daytime sleepiness in Parkinson's disease: a questionnaire survey. Mov Disord 18(3): 319-323
44. Homann CN, Suppan K, et al. (2003) Driving in Parkinson's disease - a health hazard?" J Neurol 250(12): 1439-1446
45. Iranzo A, Santamaria J (2005) Severe obstructive sleep apnea mimicking REM sleep behavior disorder. Sleep 28(2): 203-206
46. Iranzo A, Valldeoriola F, et al. (2002) Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 72(5): 661-664
47. Jansen EN, Meerwaldtt JD (1990) Madopar HBS in nocturnal symptoms of Parkinson's disease. Adv Neurol 53: 527-531
48. Juncos JL, Fabbrini G, et al. (1987) Controlled release levodopa-carbidopa (CR-5) in the management of parkinsonian motor fluctuations. Arch Neurol 44(10): 1010-1012
49. Kales A, Ansel RD, et al. (1971) Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 12(2): 397-406
50. Lai YY, Siegel JM (2003) Physiological and anatomical link between Parkinson-like disease and REM sleep behavior disorder. Mol Neurobiol 27(2): 137-152
51. Larsen JP (2003) Sleep disorders in Parkinson's disease. Adv Neurol 91: 329-334
52. Lees AJ (1987) A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease. Eur Neurol 27 [Suppl 1]: 126-134
53. Lees AJ, Blackburn NA, et al. (1988) The night-time problems of Parkinson's disease. Clin Neuropharmacol 11(6): 512-519
54. Lesser RP, Fahn S, et al. (1979) Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 29(9 Pt 1): 1253-1260
55. Manni R, Pacchetti C, et al. (2002) Hallucinations and sleep-wake cycle in PD: a 24-hour continuous polysomnographic study. Neurology 59(12): 1979-1981
56. Maria B, Sophia S, et al. (2003) Sleep breathing disorders in patients with idiopathic Parkinson's disease. Respir Med 97(10): 1151-1157
57. Mouret J (1975) Differences in sleep in patients with Parkinson's disease. Electroencephalogr Clin Neurophysiol 38(6): 653-657
58. Olson EJ, Boeve BF, et al. (2000) Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 123(Pt 2): 331-339
59. Ondo WG, Vuong KD, et al. (2002) Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 59(3): 421-424
60. Overeem S, van Hilten JJ, et al. (2002) Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness. Neurology 58(3): 498-499
61. Pahwa R, Busenbark K, et al. (1993) Clinical experience with controlled-release carbidopa/levodopa in Parkinson's disease. Neurology 43(4): 677-681
62. Pal PK, Thennarasu K, et al. (2004) Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson's disease and in their caregivers. Parkinsonism Relat Disord 10(3): 157-168
63. Pappert EJ, Goetz CG, et al. (1999) Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord 14(1): 117-121
64. Priano L, Albani G, et al. (2003) Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. Neurol Sci 24(3): 207-208
65. Razmy A, Lang AE, et al. (2004) Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 61(1): 97-102
66. Ringman JM, Simmons JH (2000) Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 55(6): 870-871
67. Roth T, Rye DB, et al. (2003) Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists. Sleep Med 4(4): 275-280
68. Rye DB, Bliwise DL, et al. (2000) FAST TRACK: daytime sleepiness in Parkinson's disease. J Sleep Res 9(1): 63-69
69. Schapira AH (2004) Restless legs syndrome: an update on treatment options. Drugs 64(2): 149-158
70. Schenck CH, Bundlie SR, et al. (1986) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9(2): 293-308
71. Schenck CH, Bundlie SR, et al. (2002) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. 1986 [classical article]. Sleep 25(2): 293-308
72. Schenck CH, Bundlie SR, et al. (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46(2): 388-393
73. Schenck CH, Bundlie SR, et al. (1987) Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. Jama 257(13): 1786-1789
74. Schenck CH, Mahowald MW (1991) Injurious sleep behavior disorders (parasomnias) affecting patients on intensive care units. Intensive Care Med 17(4): 219-224
75. Silber MH, Shepard JW Jr, et al. (1997) Pergolide in the management of restless legs syndrome: an extended study. Sleep 20(10): 878-882
76. Stern M, Roffwarg H, et al. (1968) The parkinsonian tremor in sleep. J Nerv Ment Dis 147(2): 202-210
77. Stevens S, Cormella CL et al. (2004) Daytime sleepiness and alertness in patients with Parkinson disease. Sleep 27(5): 967-972
78. Tan EK, Lum SY, et al. (2002) Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls. Neurology 58(3): 465-468
79. Tandberg E, Larsen JP, et al. (1998) A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 13(6): 895-899
80. Tandberg E, Larsen JP, et al. (1999) Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 14(6): 922-927
81. van Hilten B, Hoff JI, et al. (1994) Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch Neurol 51(9): 922-928
82. Wetter TC, Collado-Seidel V, et al. (2000) Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 23(3): 361-367